According to this, in the case of a characteristic clinical presentation, the presence of anti-SRP and anti-HMGCR autoantibodies for IMNM and anti-Mi2, anti-NXP2, anti-MDA5, anti-SAE, or anti-TIF1γ for DM renders a muscle biopsy optional. The gene discussed is IFIH1; the disease is dermatomyositis.